Emerging Nanomaterials for Biosensing and Bioimaging
A special issue of Micromachines (ISSN 2072-666X). This special issue belongs to the section "B1: Biosensors".
Deadline for manuscript submissions: closed (25 September 2023) | Viewed by 1884
Special Issue Editor
Interests: nanotheranostics; medical imaging; diagnosis; cancer therapy; biomedical imaging; molecular imaging; nanomedicine; nuclear medicine; advanced radiation therapy
Special Issue Information
Dear Colleagues,
Biomedical imaging modalities are used for the detection and diagnosis of different types of cancers and diseases in their early stages. Recently, nanomaterials have attracted much attention due to their wide-ranging applications in biomedical imaging and cancer therapy. With the progress made in nanotheranostics (both imaging and therapy agents), studying drugs’ release, accumulation in target tissues, biodistribution, and treatment effectiveness are other subjects devoted attention to.
Nanoparticles are becoming potentially transformative tools for cancer detection for a wide range of biomedical imaging modalities, including computed tomography (CT), magnetic resonance imaging (MRI), single-photon emission CT, positron emission tomography (PET), single-photon emission tomography (SPECT), ultrasound, and optical imaging. Knowledge of the correlation between the application of nanoparticles as well as biomedical imaging modalities and the development of targeted nanoprobes may provide better cancer diagnoses in the future.
These imaging modalities may facilitate earlier and more accurate diagnoses in addition to staging of most cancers.
This Special Issue calls for research papers and review articles, attempting to present recent studies on nanotheranostics used as nono-agents in various imaging modalities and platforms for cancer therapy.
Prof. Dr. Daryoush Shahbazi-Gahrouei
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Micromachines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer diagnosis
- cancer therapy
- nanoparticles
- biosensors
- biomedical imaging
